ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

City of Hope at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

City of Hope takes part in 15 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8038. Its work spans cancer treatment, immunotherapy and patient care across several tumour types. It examines personalized cell therapy for recurrent ovarian cancer and ways to manage side effects of immunotherapy.

OrganizationESMO 2026 Attendance
City of Hope
Duarte, CA
Cancer centre & hospitalExhibitor
Independent cancer research and treatment organization based in Duarte, California, with an NCI-designated comprehensive cancer centre and sites across the US.
Booth
Exhibiting at Booth 8038
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Satellite
Sat Oct 24
12:00–12:10
Opening: Why Subcutaneous Immunotherapy Now? A Nurse Led Lens
MSD - Oncology Nursing Perspectives on Subcutaneous Immunotherapy: Practical Considerations for Patient Care
Nursing & supportive care
Satellite
Sat Oct 24
12:50–13:25
Nurse Panel session: How best to implement SC IO patient services in hospital and community settings
MSD - Oncology Nursing Perspectives on Subcutaneous Immunotherapy: Practical Considerations for Patient Care · with Klinik Favoriten, Royal Derby Hospital
Nursing & supportive care
Satellite
Sat Oct 24
13:25–13:30
Conclusion remarks
MSD - Oncology Nursing Perspectives on Subcutaneous Immunotherapy: Practical Considerations for Patient Care
Nursing & supportive care
Satellite
Sat Oct 24
18:43–19:23
Navigating the RCC treatment journey
Ipsen - Treatment decisions that shape the journey in RCC and NETs · with Gustave Roussy, Arthur Child Comprehensive Cancer Centre
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers
Abstract
Sun Oct 25
09:22–09:32
3588O - Phase 1 results of XmAb819, a novel ENPP3 x CD3 bispecific, in advanced clear cell renal cell carcinoma (ccRCC)
Proffered paper 2: Genitourinary tumours, renal and urothelial
Genitourinary cancers
Talk
Sun Oct 25
10:30–11:15
Poster
Sun Oct 25
12:00–12:45
PARP inhibitors and platinum chemotherapy improve survival in pancreatic adenocarcinoma independent of HRD status
Sunday Poster Display session 4
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
Predictive response factors to CTLA4/PD-1 combinations in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Sunday Poster Display session 5
Gastrointestinal cancersBiomarkers & precision oncology
Talk
Sun Oct 25
15:00–15:15
Poster
Mon Oct 26
12:00–12:45
First-in-human study of BG-C477, a novel CEA-targeting ADC, in advanced solid tumors: Initial results in NSCLC
Monday Poster Display session 3
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at City of Hope

Tell us what you sell and we’ll find the people at City of Hope most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction